Implantable Infusion Pumps-Medical Devices Pipeline Assessment, 2017
June 2017
38
About the Report
About the Report
Implantable Infusion Pumps-Medical Devices Pipeline Assessment, 2017
Summary
GlobalData's Medical Devices sector report, "Implantable Infusion Pumps-Medical Devices Pipeline Assessment, 2017" provides an overview of Implantable Infusion Pumps currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Infusion Pumps pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Implantable Infusion Pumps under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Implantable Infusion Pumps and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to-
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Implantable Infusion Pumps under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Products
Alnylam Pharmaceuticals Inc, ALN-HTT Infusion System; Debiotech SA, MIP Device; Eksigent Technologies LLC, Implantable Drug Delivery System; Eli Lilly and Company, Drug Delivery System-Parkinson's Disease; Flowonix Medical Inc, Implanted Drug Delivery System; Flowonix Medical Inc, Prometra II Programmable Infusion System; FluidSynchrony, LLC, FluidSync Pump; Intarcia Therapeutics Inc, ITCA 650 Osmotic Pump; Medallion Therapeutics, Inc., Medallion Infusion System; Nano Precision Medical Inc, Nano Portal Capsule; University of Minnesota, Infusion Micropump; University of Southern California, Drug Infusion Pump
Companies
Alnylam Pharmaceuticals Inc, Debiotech SA, Eksigent Technologies LLC, Eli Lilly and Company, Flowonix Medical Inc, FluidSynchrony, LLC, Intarcia Therapeutics Inc, Medallion Therapeutics, Inc., Nano Precision Medical Inc, University of Minnesota, University of Southern California
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Implantable Infusion Pumps Overview 6
3 Products under Development 7
3.1 Implantable Infusion Pumps-Pipeline Products by Stage of Development 7
3.2 Implantable Infusion Pumps-Pipeline Products by Territory 8
3.3 Implantable Infusion Pumps-Pipeline Products by Regulatory Path 9
3.4 Implantable Infusion Pumps-Pipeline Products by Estimated Approval Date 10
3.5 Implantable Infusion Pumps-Ongoing Clinical Trials 11
4 Implantable Infusion Pumps-Pipeline Products under Development by Companies 12
4.1 Implantable Infusion Pumps Companies-Pipeline Products by Stage of Development 12
4.2 Implantable Infusion Pumps-Pipeline Products by Stage of Development 13
5 Implantable Infusion Pumps Companies and Product Overview 14
5.1 Alnylam Pharmaceuticals Inc Company Overview 14
5.1.1 Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Debiotech SA Company Overview 15
5.2.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Eksigent Technologies LLC Company Overview 17
5.3.1 Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Eli Lilly and Company Company Overview 18
5.4.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Flowonix Medical Inc Company Overview 19
5.5.1 Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 FluidSynchrony, LLC Company Overview 23
5.6.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Intarcia Therapeutics Inc Company Overview 24
5.7.1 Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 Medallion Therapeutics, Inc. Company Overview 26
5.8.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Nano Precision Medical Inc Company Overview 27
5.9.1 Nano Precision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 University of Minnesota Company Overview 28
5.10.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 28
5.11 University of Southern California Company Overview 29
5.11.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 29
6 Implantable Infusion Pumps- Recent Developments 30
6.1 Mar 14, 2017: Medtronic Announces Class I Recall for SynchroMed II Implantable Drug Infusion Pump 30
6.2 Mar 14, 2017: Medtronic Announces Class I Recall For SynchroMed EL Implantable Drug Infusion Pumps 30
6.3 Mar 14, 2017: Flowonix Medical And Cerebral Therapeutics Announce World-First Clinical Trial Delivering Medication Directly Into The Brain For Patients With Refractory Epilepsy 31
6.4 Feb 03, 2017: Intarcia Announces FDA Filing Acceptance of New Drug Application for ITCA 650 for the Treatment of Type 2 Diabetes 32
6.5 Oct 28, 2016: Teleflex Incorporated Signs New Agreement with Premier for Implantable Infusion Ports 32
6.6 Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions 32
7 Appendix 35
7.1 Methodology 35
7.2 About GlobalData 38
7.3 Contact Us 38
7.4 Disclaimer 38
List of Figure
1.2 List of Figures
Figure 1: Implantable Infusion Pumps-Pipeline Products by Stage of Development 7
Figure 2: Implantable Infusion Pumps-Pipeline Products by Territory 8
Figure 3: Implantable Infusion Pumps-Pipeline Products by Regulatory Path 9
Figure 4: Implantable Infusion Pumps-Pipeline Products by Estimated Approval Date 10
Figure 5: Implantable Infusion Pumps-Ongoing Clinical Trials 11
List of Table
1.1 List of Tables
Table 1: Implantable Infusion Pumps-Pipeline Products by Stage of Development 7
Table 2: Implantable Infusion Pumps-Pipeline Products by Territory 8
Table 3: Implantable Infusion Pumps-Pipeline Products by Regulatory Path 9
Table 4: Implantable Infusion Pumps-Pipeline Products by Estimated Approval Date 10
Table 5: Implantable Infusion Pumps-Ongoing Clinical Trials 11
Table 6: Implantable Infusion Pumps Companies-Pipeline Products by Stage of Development 12
Table 7: Implantable Infusion Pumps-Pipeline Products by Stage of Development 13
Table 8: Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: ALN-HTT Infusion System-Product Status 14
Table 10: ALN-HTT Infusion System-Product Description 14
Table 11: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 15
Table 12: MIP Device-Product Status 15
Table 13: MIP Device-Product Description 16
Table 14: Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 17
Table 15: Implantable Drug Delivery System-Product Status 17
Table 16: Implantable Drug Delivery System-Product Description 17
Table 17: Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 18
Table 18: Drug Delivery System-Parkinson's Disease-Product Status 18
Table 19: Drug Delivery System-Parkinson's Disease-Product Description 18
Table 20: Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 21: Implanted Drug Delivery System-Product Status 19
Table 22: Implanted Drug Delivery System-Product Description 19
Table 23: Prometra II Programmable Infusion System-Product Status 20
Table 24: Prometra II Programmable Infusion System-Product Description 20
Table 25: Flowonix Medical Inc-Ongoing Clinical Trials Overview 21
Table 26: Prometra II Programmable Infusion System-A Dose Ranging Pilot Study to Assess Intracerebroventricular (ICV) Delivery of Valproate in Subjects with Focal Seizures, with Temporal Lobe Onset with or without Secondary Generalization 22
Table 27: FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
Table 28: FluidSync Pump-Product Status 23
Table 29: FluidSync Pump-Product Description 23
Table 30: Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 31: ITCA 650 Osmotic Pump-Product Status 24
Table 32: ITCA 650 Osmotic Pump-Product Description 25
Table 33: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 34: Medallion Infusion System-Product Status 26
Table 35: Medallion Infusion System-Product Description 26
Table 36: Nano Precision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 37: Nano Portal Capsule-Product Status 27
Table 38: Nano Portal Capsule-Product Description 27
Table 39: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 28
Table 40: Infusion Micropump-Product Status 28
Table 41: Infusion Micropump-Product Description 28
Table 42: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 29
Table 43: Drug Infusion Pump-Product Status 29
Table 44: Drug Infusion Pump-Product Description 29
Table 45: Glossary 37
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.